Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility trial of CBT, sertraline, and their combination for obsessive-compulsive disorder
ISRCTN07706836Phase 4Completed
- Sponsor
- Hertfordshire Partnership University NHS Foundation Trust
- Start
- Jul 2014
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sertraline in obsessive compulsive disorder (OCD) (3 arms), sponsored by Hertfordshire Partnership University NHS Foundation Trust. Primary endpoint: Variation in Yale-Brown Obsessive Compulsive Scale at week 52. Started Jul 2014; status: completed.
02
Drugs
sertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on ISRCTN07706836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN07706836.